Zobrazeno 1 - 10
of 852
pro vyhledávání: '"Mario Boccadoro"'
Autor:
Bachisio Ziccheddu, Claudia Giannotta, Mattia D’Agostino, Giuseppe Bertuglia, Elona Saraci, Stefania Oliva, Elisa Genuardi, Marios Papadimitriou, Benjamin Diamond, Paolo Corradini, David Coffey, Ola Landgren, Niccolò Bolli, Benedetto Bruno, Mario Boccadoro, Massimo Massaia, Francesco Maura, Alessandra Larocca
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Targeted immunotherapy combinations, including the anti-CD38 monoclonal antibody (MoAb) daratumumab, have shown promising results in patients with relapsed/refractory multiple myeloma (RRMM), leading to a considerable increase in progression
Externí odkaz:
https://doaj.org/article/a0836646950848c8a7696721b96ea559
Autor:
Francesca Fazio, Maria Teresa Petrucci, Laura Corvatta, Alfonso Piciocchi, Roberta Della Pepa, Paola Tacchetti, Maurizio Musso, Renato Zambello, Angelo Belotti, Sara Bringhen, Elisabetta Antonioli, Concetta Conticello, Nicola Di Renzo, Valerio De Stefano, Pellegrino Musto, Barbara Gamberi, Daniele Derudas, Mario Boccadoro, Massimo Offidani, Sonia Morè
Publikováno v:
eJHaem, Vol 5, Iss 3, Pp 485-493 (2024)
Abstract Belantamab mafodotin is the first‐in‐class antibody‐drug conjugates targeting B‐cell maturation antigen to have demonstrated effectiveness in triple‐class refractory multiple myeloma (TCR‐MM) patients. We performed a retrospectiv
Externí odkaz:
https://doaj.org/article/7725cc7a33b84acb8c1ed168063ccd72
Autor:
Mattia D’Agostino, Delia Rota-Scalabrini, Angelo Belotti, Luca Bertamini, Maddalena Arigoni, Giovanni De Sabbata, Giuseppe Pietrantuono, Anna Pascarella, Patrizia Tosi, Francesco Pisani, Norbert Pescosta, Marina Ruggeri, Jennifer Rogers, Martina Olivero, Mariagrazia Garzia, Piero Galieni, Ombretta Annibali, Federico Monaco, Anna Marina Liberati, Salvatore Palmieri, Paola Stefanoni, Elena Zamagni, Benedetto Bruno, Raffaele Adolfo Calogero, Mario Boccadoro, Pellegrino Musto, Francesca Gay
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Additional copies of chromosome 1 long arm (1q) are frequently found in multiple myeloma (MM) and predict high-risk disease. Available data suggest a different outcome and biology of patients with amplification (Amp1q, ≥4 copies of 1q) vs.
Externí odkaz:
https://doaj.org/article/de9018c7e2514cbf84b93ad1e4029993
Autor:
Roberto Mina, Maria Teresa Petrucci, Francesca Bonello, Velia Bongarzoni, Riccardo Saccardi, Giuseppe Bertuglia, Andrea Mengarelli, Andrea Spadaro, Chiara Lisi, Paola Curci, Roberto Massimo Lemoli, Stelvio Ballanti, Rita Floris, Luca Cupelli, Patrizia Tosi, Attilio Olivieri, Delia Rota-Scalabrini, Clotilde Cangialosi, Chiara Nozzoli, Barbara Anaclerico, Francesca Fazio, Benedetto Bruno, Katia Mancuso, Paolo Corradini, Giuseppe Milone, Mario Boccadoro
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
High-dose melphalan plus autologous stem cell transplantation (ASCT) is a standard of care for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM), and adequate hematopoietic stem cell (HSC) collection is crucial to ensure hemat
Externí odkaz:
https://doaj.org/article/9166e5bc73e84f42bc5fc785d6d557e5
Autor:
Mattia D’agostino, Davine Hofste Op Bruinink, Mark van Duin, Delia Rota-Scalabrini, Luca Bertamini, Rowan Kuiper, Angelo Belotti, Vincenzo Marasco, Stefania Oliva, Elena Rivolti, Jennifer Rogers, Roberto Mina, Mariella Grasso, Antonio Ledda, Massimo Offidani, Monica Galli, Michele Cavo, Annemiek Broijl, Pellegrino Musto, Benedetto Bruno, Mario Boccadoro, Pieter Sonneveld, Francesca Gay
Publikováno v:
HemaSphere, Vol 7, p e36094ab (2023)
Externí odkaz:
https://doaj.org/article/3b796f80d4e14f24afec4a2aa1b32606
Autor:
Vittorio Montefusco, Anna Maria Cafro, Gloria Margiotta-Casaluci, Francesca Patriarca, Roberto Mina, Mattia D’agostino, Anna Benedetta Dalla Palma, Rita Rizzi, Angelo Genua, Francesca Fazio, Laura Paris, Angelo Belotti, Ilaria Rizzello, Concetta Conticello, Carmelo Carlo-Stella, Mario Boccadoro
Publikováno v:
HemaSphere, Vol 7, p e729785d (2023)
Externí odkaz:
https://doaj.org/article/c18d8975f59b4d80b1aa597a9557ee91
Autor:
Mattia D’agostino, Sara Bringhen, Nicola Giuliani, Elisabetta Antonioli, Renato Zambello, Francesco Cattel, Roberto Ria, Alessandro Allegra, Giovanna Leonardi, Angelo Belotti, Piero Galieni, Gloria Margiotta-Casaluci, Maria Cantonetti, Valentina Cotugno, Barbara Gamberi, Fabrizio Pane, Anna Marina Liberati, Patrizia Tosi, Maide Maria Cavalli, Donato Mannina, Giulia Benevolo, Silvia Mangiacavalli, Andrea Evangelista, Giovannino Ciccone, Mario Boccadoro, Benedetto Bruno, Alessandra Larocca
Publikováno v:
HemaSphere, Vol 7, p e993869a (2023)
Externí odkaz:
https://doaj.org/article/81479fd2b8f74f5088b1123fe168121b
Autor:
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota-Scalabrini, Francesca Bonello, Caterina Musolino, Michele Cea, Renato Zambello, Paola Tacchetti, Angelo Belotti, Claudia Cellini, Laura Paris, Mariella Grasso, Sara Aquino, Lorenzo De Paoli, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Mario Boccadoro, Federico Monaco, Paolo Corradini, Alessandra Larocca
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/85d07ceb4ffb4350a7da29ebc2f8331e
Autor:
Pieter Sonneveld, Sonja Zweegman, Michele Cavo, Kazem Nasserinejad, Annemiek Broijl, Rosella Troia, Ludek Pour, Sandra Croockewit, Paolo Corradini, Francesca Patriarca, Kalung Wu, Jolanda Droogendijk, Gerard Bos, Roman Hajek, Maria Teresa Petrucci, Paula Ypma, Nicholas Zojer, Monique C. Minnema, Mario Boccadoro
Publikováno v:
HemaSphere, Vol 6, Iss 10, p e786 (2022)
This phase 2 trial investigated reinduction with carfilzomib, pomalidomide, and dexamethasone (KPd) and continuous pomalidomide/dexamethasone in patients at first progression during lenalidomide maintenance. The second objective was to evaluate high-
Externí odkaz:
https://doaj.org/article/98b6b44e179b444cb4be980901930363
Autor:
Stefania Oliva, Davine Hofste op Bruinink, Lucie Rihova, Mattia D’Agostino, Lucia Pantani, Andrea Capra, Bronno van der Holt, Rossella Troia, Maria Teresa Petrucci, Tania Villanova, Pavla Vsianska, Romana Jugooa, Claudia Brandt-Hagens, Milena Gilestro, Massimo Offidani, Rossella Ribolla, Monica Galli, Roman Hajek, Francesca Gay, Michele Cavo, Paola Omedé, Vincent H. J. van der Velden, Mario Boccadoro, Pieter Sonneveld
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 6, Pp 1-9 (2021)
Abstract Minimal residual disease (MRD) by multiparameter flow cytometry (MFC) is the most effective tool to define a deep response in multiple myeloma (MM). We conducted an MRD correlative study of the EMN02/HO95 MM phase III trial in newly diagnose
Externí odkaz:
https://doaj.org/article/fff4989bfcb448fa8d1e3442a6743211